Increasing Cost Of Insulin Sparks Concern.

reports there is growing concern and outrage about the increasing cost of insulin. The article explains that Eli Lilly, Sanofi, and Novo Nordisk control 99% “of the world’s insulin,” and according to the American Diabetes Association, the average price almost tripled from 2002 to 2013. http://thehill.com/policy/healthcare/393378-skyrocketing-insulin-prices-provoke-new-outrage